A detailed history of Koshinski Asset Management, Inc. transactions in Chimerix Inc stock. As of the latest transaction made, Koshinski Asset Management, Inc. holds 37,000 shares of CMRX stock, worth $32,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,000
Previous 37,000 -0.0%
Holding current value
$32,560
Previous $32,000 6.25%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$0.87 - $1.05 $2,610 - $3,150
-3,000 Reduced 7.5%
37,000 $32,000
Q1 2024

May 08, 2024

BUY
$0.91 - $1.26 $36,400 - $50,400
40,000 New
40,000 $42,000
Q2 2022

Jul 12, 2022

SELL
$1.34 - $5.34 $6,700 - $26,700
-5,000 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$4.58 - $6.8 $139,625 - $207,304
-30,486 Reduced 85.91%
5,000 $23.2 Million
Q4 2020

Feb 02, 2021

BUY
$2.43 - $5.42 $86,230 - $192,334
35,486 New
35,486 $2.07 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $77.1M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.